Whether it’s “the liver” or “the breast of the breast” — some of the links between thyroid cancer and breast cancer — will be asked, “Dr. Lee, why do you have thyroid and breast diseases in one of the rooms? What does it matter?” At this point, there’s always a enthusiast aunt who says to me, “Why do you keep it in one section? Because these two diseases, whatever they come first, are bound to have another disease, and they can’t hide!” I do find that many patients suffer from both diseases in clinical work, but whether the mammography causes thyroid disease, or the thyroid disease causes breast disease, or whether the two have a common basis and cause of morbidity? I have summarized some of the research findings, both in the country and abroad, to give you a Kopp on the link between milk and milk, in the hope of helping a large number of patients. A natural pair of “sisters” who say that thyroid and breast are good friends are two examples. One example is the removal of thyroid glands from mammals, which turns them into thyroid reduction, which prevents them from developing their breasts well and, when the thyroid is supplemented, the breasts of these animals are developing well; another example is the fact that in 1896 a doctor abroad tried to treat late-stage breast cancer with thyroid formulations, which significantly eased the patient’s condition. It is important to know if the mammary is normal and is related to estrogen and urogen in the body, which can affect the metabolism of estrogen and urogen. If there is a thyroid problem, it is likely that it will not be recognized by the six relatives and that the mammogram will cause breast disease. In recent decades, as the incidence of breast cancer and thyroid cancer has increased year by year, and as treatments have improved, the number of survivors of breast and thyroid cancer has increased, especially in the thyroid, which has led to increased concern about the causes of and links between thyroid cancer and the high incidence of breast cancer. Especially between 1996 and 2005, the incidence of thyroid cancer in the United States increased significantly and at a fast pace, with 5.8 per cent for men and 7.1 per cent for girls per year; the rate of increase was faster than for other cancers. In 2008, thyroid cancer became the seventh most common malignant neoplasm in the United States, rising fifth place in 2013, and it is estimated that the incidence of thyroid cancer in the United States will rise to third place in 2019, by which time 1 million people will survive. In this context, American scholars have concentrated on two studies, one on the survival status of gland cancer survivors in an epidemiological survey of the effects of thyroid cancer. Then this is very similar to what is currently happening in my country … Ten years before the risk of disease among citizens of developed countries, and therefore the research of our scholars is well founded. In a 2008 study by American scholars of the causes of the high incidence of thyroid cancer, it was concluded that the causes of the high incidence of thyroid cancer were likely mainly due to their improved detection techniques and methods, leading to the detection of thyroid microcancer; On the other hand, the pathological signs of thyroid cancer have changed; The third is that environmental factors also play a customized role, with clearly vague and unsatisfactory conclusions. There have also been studies by scholars on the causes of the high incidence of thyroid cancer, which, in addition to reprovening the identified risk factors (historic history of exposure to ionizing radiation and benign thyroid diseases), have unfortunately not been identified in detail, but have also revealed some particularly noteworthy relevant factors: worldwide, the female thyroid rate is twice as high as that of males and the incidence is higher than that of males, with average age, with females at 47 and 53 years of age, all of which indicate that women may have a separate risk factor, and that the female thyroid is related to endocrine levels, especially estrogen. The thyroid and mammary are both endocrine-related organs, regulated by the hypothalamus arcs, and the thyroid and breast cancers are gender-friendly for women and are hormonally influenced and therefore inherently related. The “yes and no” evidence between thyroid cancer and breast cancer suggests that there is a significant increase in the risk of re-emergence of breast cancer among the rich thyroid patients, as well as a significant increase in the risk of re-emergence of thyroid cancer among breast cancer patients. Breast cancer is somewhat related to thyroid cancer. Some of the late- and mid-term breast cancer patients may be excruciating to the thyroid glands during treatment or chemotherapy, which can lead to functional disorders and impairments, thus increasing the risk of thyroid cancer. Second, cases of thyroid cancer can lead to changes in hormonal levels in the body, which increases the probability of breast cancer occurring, due to abnormal thyroid functions and delays in treatment. Patients need to avoid exposure to harmful substances at normal times, and need to take care of personal care and maintain a sense of pleasure.
Breast cancer
